Clinical Trial

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This multicentre, randomized controlled trial evaluates the effect and safety of integrating acupuncture with immunotherapeutic sensitization in treating NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four cycles of standard ICIs combined with chemotherapy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-06-12; most recent amendment 2025-12-09.
Status change: Recruiting → Active, Not Recruiting 2025-12-09
Status change: Not Yet Recruiting → Recruiting 2025-09-03
Trial Details
NCT Number NCT06461338
Lead Sponsor Guangzhou University of Traditional Chinese Medicine
Collaborators: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine
Conditions Non-small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma
Enrollment 60 participants
Start Date 2024-08-15
Primary Completion 2026-07 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-12-17